Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Interra Acquisition HK$1 billion IPO
We advised the SPAC on its IPO and HKEX listing
Niagara Mohawk Power $500 million green senior notes offering
The investment-grade notes are due 2052
BBVA $1.75 billion senior non-preferred notes offering
We advised BBVA on its offering of senior non-preferred fixed-to-fixed-rate notes
Mitsubishi HC Capital $500 million senior notes offering
We advised Mitsubishi HC Capital on its senior notes offering
Sumitomo Mitsui Trust Bank $1 billion senior notes offering
We advised Sumitomo Mitsui Trust Bank on the update of its global MTN program and senior notes offering
Alnylam Pharmaceuticals $1.035 billion convertible senior notes offering
The 1% convertible notes are due 2027
Oesterreichische Kontrollbank $1 billion notes offering
The investment-grade notes are due 2027
Pacific LifeCorp $750 million senior notes offering
The investment-grade notes are due 2052
Toronto-Dominion Bank $3 billion notes offering
The investment-grade debt offering consists of two tranches
Norinchukin Bank $1 billion senior notes offering
The senior notes are due 2027 and 2032